Sobi to trim staff as Pfizer manufacturing contract ends early
March 24, 2022As biotech retreats, gene therapy companies retrench and redraw plans
March 24, 2022The regulator has demanded the partners run an additional clinical trial to support approval of sintilimab in a decision that will have ripple effects on the development and cost of cancer immunotherapies in the U.S.
